Analysis highlights pros and cons of private equity involvement in Mohs surgery, indicating potential impacts on care.
*Martin Army Community Hospital, Fort Benning, Georgia †Dermatology Institute for Skin Cancer and Cosmetic Surgery, Affiliate of Anne Arundel Dermatology, Newnan, Georgia The authors have indicated no significant interest with commercial supporters. D. Harvey works for a PE group but gave an honest appraisal of the pros and cons of PE in Mohs Surgery. The PE company I work for did not influence me in this manuscript and was not aware that I helped write this article. These are my views only.
No takes yet. Share an insight, caveat, or question.
McTighe et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: